期刊文献+

维持性血液透析患者血清胱抑素C与细胞因子及颈动脉病变的关系 被引量:7

Relationship of serum cystatin C level with cytokines and carotid atherosclerosis in maintenance hemodialysis patients
原文传递
导出
摘要 目的研究维持性血液透析(MHD)患者的血清胱抑素C(半胱氨酸蛋白酶抑制剂,CysC)水平的变化及其与细胞因子及颈动脉病变的关系。方法选择透析龄超过6个月的MHD患者110例(MHD组)和健康对照组60例为对象。用免疫透射比浊法检测CysC;超声检查颈动脉病变的程度;检测高敏C反应蛋白(hsCRP)、总同型半胱氨酸(tHcy)、血清白介素1β(IL-1β)、IL-6、肿瘤坏死因子α(TNF-α)水平。分析CysC水平与细胞因子及颈动脉病变的关系。结果MHD组血清CysC水平为(6.19±0.95)mg/L,显著高于健康对照组的(0.76±0.21)mg/L(P〈0.01)。MHD组hsCRP、tHcy、IL—1β、IL-6、TNF-α水平均显著高于健康对照组(P〈0.05或〈0.01)。MHD组患者颈动脉内膜中层厚度(IMT)及斑块形成、颈动脉硬化的患病率均显著高于健康对照组(P〈0.05或P〈0.01)。直线相关分析显示,MHD组血CysC水平与hsCRP、tHcv、IL-1β、IL-6、TNF-α、IMT及斑块形成、颈动脉硬化的患病率呈正相关;与透析龄、收缩压、iPTH亦呈正相关(P〈0.05或P〈0.01)。多因素逐步回归分析显示,CysC、hsCRP、tHcy和年龄是MHD患者颈动脉病变的危险因素。结论血液透析不能有效清除Cvsc等大分子物质,随着透析龄的增加,MHD患者血清CysC水平逐渐升高。CysC与hsCRP等微炎性反应指标及tHcy、颈动脉病变呈正相关,血清CysC水平升高可能是MHD患者并发动脉粥样硬化的危险因素之一。 Objective To investigate the serum cystatin C (CysC) level and explore its relationship with cytokines and atherosclerosis (AS) in maintenance hemodialysis (MHD) patients. Methods A total of 110 stable MHD patients undergoing hemodialysis for at least six months and 60 healthy control people were enrolled in the study. Serum levels of CysC and high-sensitivity C- reactive protein (hsCRP) were measured by immunoturbidimetry. The serum levels of total homocysteine (tHcy), IL-1β, IL-6 and TNF-α were determined by ELISA. Prevalence of atherosclerosis was detected by carotid uhrasonography. The relationship of CysC level and cardiac geometry incidence in MHD patients was analyzed by Logistic regression model. Results The serum CysC level was significantly higher in MHD patients as compared with healthy controls [(6.19+0.95) mg/L vs (0.76+0.21) mg/L, P〈0.01], and the serum levels of hsCRP, tHcy, IL-1β,IL-6, TNF-α were significantly higher in MHD patients than those in healthy control group (P〈 0.05 or P〈0.01). The serum CysC level was higher in MHD patients with carotid artery atherosclerosis compared to patients without carotid artery atherosclerosis (P〈0.05). CysC was positively correlated with hsCRP, tHcy, IL-1β, IL-6, TNF-α respectively (P〈0.05 or P〈0.01), and was positively correlated with carotid intimal medial thickness (IMT) and AS. Besides, a negative correlation was found between the serum CysC level and the serum albumin level (P〈0.05), while CysC was positively correlated with dialysis duration, systolic pressure and iPTH (P〈0.05). Conclusion Serum CysC level is significantly higher in MHD patients and is correlated with hsCRP, tHcy, IL-1β, IL-6, TNF-α as well as carotid artery atherosclerosis, which indicates that CysC is an independent risk factor of AS in MHD patients.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2011年第11期802-806,共5页 Chinese Journal of Nephrology
基金 上海市卫生局科技发展基金(2009255) 上海市闸北区卫生局科研基金(2009ZBMXK02)
关键词 血液透析 西司他丁类 细胞因子类 动脉粥样硬化 Hemodialysis Cystatins Cytokines Atherosclerosis
  • 相关文献

参考文献16

  • 1Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis, 2004, 44: 198-206.
  • 2Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004, 351: 1296-1305.
  • 3Dharnidharka VR, Kwon G, Srevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis, 2002, 40: 221-227.
  • 4林钐,邓跃毅,张先闻.胱抑素C及CGFR评价慢性肾脏病肾功能的临床意义[J].中国中西医结合肾病杂志,2010,11(9):807-809. 被引量:12
  • 5Koeni W, concentration disease and than simply Chem, 2005, Twardella D, Brenner H, et al. Plasma of cystation C in patients with coronary heart risk for secondary cardiovascular events: more a nmrker of glomerular filtration rate. Clin 51:321-327.
  • 6Singh D, Whooley MA, Ix JH, et al. Asspciation of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant, 2007, 22: 1087-1092.
  • 7Shlipak MG, Sarnak MJ, Katz R, et al. Cystation C and the risk of death and cardiovascular events among elderly persons. N Engl J Med, 2005, 352: 2049-2060.
  • 8Ix JH, Shlipak MG, Chertow GM, et al. Association of cystation C with mortality, cardiovascular events and incident heart failure among persons with coronary heart disease. Circulation, 2007, 115: 173-179.
  • 9司晓芸,毕晓红,姚缨,乐萍,吴小燕.维持性血液透析患者血清胱抑素C浓度与左心室肥厚的相关分析[J].中华全科医师杂志,2009,8(7):480-482. 被引量:1
  • 10Wang J, Sim AS, Wang XL, et al. Relations between markers of renal function, coronary risk factors and the and severity of coronary artery disease.Atheroselerosis, 2008, 197: 853-859.

二级参考文献22

  • 1戴再友,李云生,陈晓莉,吴光华.110例继发性肾脏病患者血清胱抑素C的变化及临床相关研究[J].中原医刊,2004,31(16):1-2. 被引量:3
  • 2Singh D,Whooley MA, Ix JH, et al. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant, 2007, 22: 1087-1092.
  • 3Wang J, Sire AS, Wang XL, et al. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis, 2008, 197:853-859.
  • 4Anonymous. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis, 2002, 39 (Suppl 2):S1-S246.
  • 5Guidelines Committee. 2003 official journal of the International Society of Hypertension and the European Society of Hypertension. J Hypertens, 2003, 21: 1018-1019.
  • 6Ix JH,Shlipak MG, Chertow GM, et al. Association of cystatin C with mortality, cardiovascular events and incident heart failure among persons with coronary heart disease. Circulation, 2007, 115: 173-179.
  • 7Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med, 2006, 145: 237-246.
  • 8Ix JH, Shlipak MG,Chertow GM, et al. Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail, 2006, 12:601-607.
  • 9Djousse L,Kurth T, Gaziano JM. Cystatin C and risk of heart failure in the Physicians Health Study (PHS). Am Heart J, 2008, 155: 82-86.
  • 10Wang J, Sire AS, Wang XL, et al. Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease. Atherosclerosis, 2008, 197 : 853 -859.

共引文献13

同被引文献60

引证文献7

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部